CSG initiated with an Overweight at Cantor Fitzgerald

Cantor Fitzgerald analyst Brett Knoblauch initiated coverage of CSG with an Overweight rating and $65 price target. The firm believes the market is underappreciating the growth potential from CSG’s core business and its ability to execute on strategic M&A, and thinks shares are attractive due to its trading at a discount to peers and future organic growth should nearly double the average growth rate over the last 10 years, the analyst tells investors in a research note.